Streamline expects $4.5 million of additional liquidity will enable achievement of previously announced adjusted EBITDA breakeven of $15.5 million of installed SaaS ARR during the second half of fiscal 2024 Expanded board of directors with appointment of CEO Benjamin Stilwill and Matthew Etheridge
Atlanta, GA , April 22, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM) , a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced that it
700-Bed health system adds eValuator ™ , becomes second healthcare provider leveraging both eValuator and RevID to improve revenue integrity pre-bill Atlanta, GA , April 25, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable
Following an efficient implementation process, a leading Florida -based healthcare provider is expanding its footprint and utilization of eValuator Atlanta, GA , April 29, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable
14% growth of SaaS revenue in fiscal 2023 compared to fiscal 2022 $0.4 million of adjusted EBITDA generated in the fourth quarter of fiscal 2023 compared to ( $0.2 million ) during the fourth quarter of fiscal 2022; $2.4 million of adjusted EBITDA improvement in fiscal 2023 vs.